{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:24:30Z","timestamp":1791307470766,"version":"4.3.1"},"reference-count":123,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.retram.2016.04.003","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T14:33:11Z","timestamp":1464877991000},"page":"97-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Stem cells for the treatment of heart failure"],"prefix":"10.1016","volume":"64","author":[{"given":"P.","family":"Menasch\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Vanneaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.retram.2016.04.003_bib0620","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1161\/CIRCRESAHA.116.304386","article-title":"Meta-analysis of cell therapy trials for patients with heart failure\u00a0\u2013\u00a0an update","volume":"116","author":"Fisher","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.retram.2016.04.003_bib0625","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.amjcard.2013.03.021","article-title":"Meta-analysis of stem cell therapy in chronic ischemic cardiomyopathy","volume":"112","author":"Kandala","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.retram.2016.04.003_bib0630","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.yjmcc.2010.06.010","article-title":"Cardiac cell therapy: lessons from clinical trials","volume":"50","author":"Menasch\u00e9","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.retram.2016.04.003_bib0635","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.stem.2013.05.008","article-title":"Cardiac stem cell therapy and the promise of heart regeneration","volume":"12","author":"Garbern","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.retram.2016.04.003_bib0640","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/j.1582-4934.2011.01468.x","article-title":"Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts","volume":"16","author":"den Haan","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.retram.2016.04.003_bib0645","doi-asserted-by":"crossref","first-page":"e0131446","DOI":"10.1371\/journal.pone.0131446","article-title":"Enhanced electrical integration of engineered human myocardium via intramyocardial versus epicardial delivery in infarcted rat hearts","volume":"10","author":"Gerbin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.retram.2016.04.003_bib0650","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2015.05.026","article-title":"Dynamics of cell generation and turnover in the human heart","volume":"161","author":"Bergmann","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.retram.2016.04.003_bib0655","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCRESAHA.111.262584","article-title":"Mitotically inactivated embryonic stem cells can be used as an in vivo feeder layer to nurse damaged myocardium after acute myocardial infarction: a preclinical study","volume":"111","author":"Burt","year":"2012","journal-title":"Circ Res"},{"issue":"Database issue","key":"10.1016\/j.retram.2016.04.003_bib0660","doi-asserted-by":"crossref","first-page":"D1241","DOI":"10.1093\/nar\/gkr828","article-title":"ExoCarta 2012: database of exosomal proteins, RNA and lipids","volume":"40","author":"Mathivanan","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.retram.2016.04.003_bib0665","doi-asserted-by":"crossref","DOI":"10.1002\/stem.2078","article-title":"Human induced pluripotent stem cell-derived microvesicles transmit RNAs and proteins to recipient mature heart cells modulating cell fate and behavior","author":"Bobis-Wozowicz","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.retram.2016.04.003_bib0670","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jacc.2015.05.068","article-title":"Fibroblasts rendered antifibrotic, antiapoptotic, and angiogenic by priming with cardiosphere-derived extracellular membrane vesicles","volume":"66","author":"Tseliou","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.retram.2016.04.003_bib0675","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12015-014-9545-9","article-title":"A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles","volume":"11","author":"Akyurekli","year":"2015","journal-title":"Stem Cell Rev"},{"key":"10.1016\/j.retram.2016.04.003_bib0680","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/cvr\/cvu167","article-title":"Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction","volume":"103","author":"Barile","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.retram.2016.04.003_bib0685","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.stemcr.2014.04.006","article-title":"Exosomes as critical agents of cardiac regeneration triggered by cell therapy","volume":"2","author":"Ibrahim","year":"2014","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.retram.2016.04.003_bib0690","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/CIRCRESAHA.117.305990","article-title":"Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction","volume":"117","author":"Khan","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.retram.2016.04.003_bib0695","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/ATVBAHA.113.300138","article-title":"MicroRNAs in stem cell function and regenerative therapy of the heart","volume":"33","author":"Seeger","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.retram.2016.04.003_bib0700","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCRESAHA.116.304360","article-title":"Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology","volume":"116","author":"Gray","year":"2015","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.retram.2016.04.003_bib0705","doi-asserted-by":"crossref","first-page":"e4722","DOI":"10.1371\/journal.pone.0004722","article-title":"Transfer of microRNAs by embryonic stem cell microvesicles","volume":"4","author":"Yuan","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.retram.2016.04.003_bib0710","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jchf.2013.08.008","article-title":"Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in myocardial repair","volume":"2","author":"Cheng","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.retram.2016.04.003_bib0715","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jacc.2014.12.027","article-title":"Human ventricular unloading induces cardiomyocyte proliferation","volume":"65","author":"Canseco","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.retram.2016.04.003_bib0720","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1634\/stemcells.2006-0374","article-title":"Cellular cardiomyoplasty: improvement of left ventricular function correlates with the release of cardioactive cytokines","volume":"25","author":"Ebelt","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.retram.2016.04.003_bib0725","first-page":"2204","article-title":"Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice","volume":"119","author":"Matsuura","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.retram.2016.04.003_bib0730","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.yjmcc.2010.09.015","article-title":"Implantation of cardiac progenitor cells using self-assembling peptide improves cardiac function after myocardial infarction","volume":"49","author":"Tokunaga","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.retram.2016.04.003_bib0735","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/cvr\/cvq290","article-title":"Human cardiac and bone marrow stromal cells exhibit distinctive properties related to their origin","volume":"89","author":"Rossini","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.retram.2016.04.003_bib0740","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5966\/sctm.2011-0015","article-title":"Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair","volume":"1","author":"Oskouei","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.retram.2016.04.003_bib0745","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jacc.2011.11.029","article-title":"Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells","volume":"59","author":"Li","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.retram.2016.04.003_bib0750","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12015-012-9367-6","article-title":"Comparison of cardiac stem cells and mesenchymal stem cells transplantation on the cardiac electrophysiology in rats with myocardial infarction","volume":"9","author":"Zheng","year":"2013","journal-title":"Stem Cell Rev"},{"key":"10.1016\/j.retram.2016.04.003_bib0755","doi-asserted-by":"crossref","first-page":"e116281","DOI":"10.1371\/journal.pone.0116281","article-title":"Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction","volume":"9","author":"Citro","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.retram.2016.04.003_bib0760","doi-asserted-by":"crossref","first-page":"e001101","DOI":"10.1161\/JAHA.114.001101","article-title":"Anti-inflammatory peptides from cardiac progenitors ameliorate dysfunction after myocardial infarction","volume":"3","author":"Liu","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.retram.2016.04.003_bib0765","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1253\/circj.CJ-15-0557","article-title":"The quest for the adult cardiac stem cell","volume":"79","author":"Noseda","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.retram.2016.04.003_bib0770","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jacc.2013.08.724","article-title":"Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction)","volume":"63","author":"Malliaras","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.retram.2016.04.003_bib0775","first-page":"2776","article-title":"The ALCADIA (Autologous Human Cardiac-Derived Stem cell To Treat Ischemic Cardiomyopathy) trial (Abstract)","volume":"126","author":"Takehara","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.retram.2016.04.003_bib0780","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/CIRCRESAHA.116.304671","article-title":"Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial","volume":"116","author":"Ishigami","year":"2015","journal-title":"Circ Res"},{"issue":"11 Suppl.\u00a01","key":"10.1016\/j.retram.2016.04.003_bib0785","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1161\/CIRCULATIONAHA.112.092627","article-title":"Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance","volume":"126","author":"Chugh","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.retram.2016.04.003_bib0790","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature13309","article-title":"c-kit+ cells minimally contribute cardiomyocytes to the heart","volume":"509","author":"van Berlo","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.retram.2016.04.003_bib0795","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI40120","article-title":"A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates","volume":"120","author":"Blin","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.retram.2016.04.003_bib0800","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature13233","article-title":"Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts","volume":"510","author":"Chong","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.retram.2016.04.003_bib0805","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nbt1327","article-title":"Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts","volume":"25","author":"Laflamme","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.retram.2016.04.003_bib0810","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.scr.2009.05.004","article-title":"Improvement of mouse cardiac function by hESC-derived cardiomyocytes correlates with vascularity but not graft size","volume":"3","author":"van Laake","year":"2009","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.retram.2016.04.003_bib0815","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/14653249.2011.623690","article-title":"Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition","volume":"14","author":"Yeghiazarians","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.retram.2016.04.003_bib0820","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1016\/j.biomaterials.2013.02.022","article-title":"The use of aggregates of purified cardiomyocytes derived from human ESCs for functional engraftment after myocardial infarction","volume":"34","author":"Moon","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.retram.2016.04.003_bib0825","article-title":"Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience","author":"Menasch\u00e9","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.retram.2016.04.003_bib0830","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.biotechadv.2013.08.009","article-title":"Technological progress and challenges towards cGMP manufacturing of human pluripotent stem cells based therapeutic products for allogeneic and autologous cell therapies","volume":"31","author":"Abbasalizadeh","year":"2013","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.retram.2016.04.003_bib0835","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/ten.teb.2014.0662","article-title":"Signaling pathways and gene regulatory networks in cardiomyocyte differentiation","volume":"21","author":"Parikh","year":"2015","journal-title":"Tissue Eng Part B Rev"},{"key":"10.1016\/j.retram.2016.04.003_bib0840","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/CIRCRESAHA.110.227512","article-title":"Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview","volume":"111","author":"Mummery","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.retram.2016.04.003_bib0845","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1089\/scd.2009.0483","article-title":"Islet-1 cells are cardiac progenitors present during the entire lifespan: from the embryonic stage to adulthood","volume":"19","author":"Genead","year":"2010","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.retram.2016.04.003_bib0850","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nmeth.3448","article-title":"Chemically defined, albumin-free human cardiomyocyte generation","volume":"12","author":"Lian","year":"2015","journal-title":"Nat Methods"},{"key":"10.1016\/j.retram.2016.04.003_bib0855","doi-asserted-by":"crossref","first-page":"e0131123","DOI":"10.1371\/journal.pone.0131123","article-title":"Treatment with hESC-derived myocardial precursors improves cardiac function after a myocardial infarction","volume":"7","author":"Ye","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.retram.2016.04.003_bib0860","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.biomaterials.2012.11.055","article-title":"The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells","volume":"34","author":"Rao","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.retram.2016.04.003_bib0865","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2009.06.016","article-title":"Control of stem cell fate by physical interactions with the extracellular matrix","volume":"5","author":"Guilak","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.retram.2016.04.003_bib0870","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm.3267","article-title":"Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies","volume":"19","author":"Lee","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.retram.2016.04.003_bib0875","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nbt.1947","article-title":"An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells","volume":"29","author":"Tang","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.retram.2016.04.003_bib0880","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.stem.2012.09.013","article-title":"Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes","volume":"12","author":"Tohyama","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.retram.2016.04.003_bib0885","doi-asserted-by":"crossref","first-page":"709","DOI":"10.5966\/sctm.2012-0066","article-title":"Apoptotic susceptibility to DNA damage of pluripotent stem cells facilitates pharmacologic purging of teratoma risk","volume":"1","author":"Smith","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.retram.2016.04.003_bib0890","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.stemcr.2015.02.016","article-title":"Elimination of tumorigenic human pluripotent stem cells by a recombinant lectin-toxin fusion protein","volume":"4","author":"Tateno","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.retram.2016.04.003_bib0895","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.stem.2011.03.013","article-title":"A precarious balance: pluripotency factors as lineage specifiers","volume":"8","author":"Loh","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.retram.2016.04.003_bib0900","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4161\/cc.6.1.3633","article-title":"Oct-3\/4: not just a gatekeeper of pluripotency for embryonic stem cell, a cell fate instructor through a gene dosage effect","volume":"6","author":"Stefanovic","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.retram.2016.04.003_bib0905","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1196\/annals.1334.018","article-title":"Administration of allogenic stem cells dosed to secure cardiogenesis and sustained infarct repair","volume":"1049","author":"Behfar","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.retram.2016.04.003_bib0910","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1634\/stemcells.2007-0133","article-title":"Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats","volume":"25","author":"Tomescot","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.retram.2016.04.003_bib0915","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1161\/CIRCULATIONAHA.109.927293","article-title":"Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells","volume":"122","author":"Bel","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.retram.2016.04.003_bib0920","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.healun.2014.10.008","article-title":"Long-term functional benefits of human embryonic stem cell-derived cardiac progenitors embedded into a fibrin scaffold","volume":"34","author":"Bellamy","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.retram.2016.04.003_bib0925","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/stem.1796","article-title":"Concise review: genomic instability in human stem cells: current status and future challenges","volume":"32","author":"Oliveira","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.retram.2016.04.003_bib0930","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/eurheartj\/ehv189","article-title":"Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report","volume":"36","author":"Menasch\u00e9","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.retram.2016.04.003_bib0935","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","article-title":"Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1\/2 studies","volume":"385","author":"Schwartz","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.retram.2016.04.003_bib0940","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2013.02.071","article-title":"Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics","volume":"61","author":"Bartunek","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.retram.2016.04.003_bib0945","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/eurheartj\/ehv136","article-title":"Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial)","volume":"36","author":"Mathiasen","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.retram.2016.04.003_bib0950","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2014.03.009","article-title":"Stem cell imaging: from bench to bedside","volume":"14","author":"Nguyen","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.retram.2016.04.003_bib0955","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00259-014-2858-8","article-title":"In-vivo comparison of the acute retention of stem cell derivatives and fibroblasts after intramyocardial transplantation in the mouse model","volume":"41","author":"Lang","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.retram.2016.04.003_bib0960","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/CIRCRESAHA.111.243071","article-title":"Empowering adult stem cells for myocardial regeneration","volume":"109","author":"Mohsin","year":"2011","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.retram.2016.04.003_bib0965","doi-asserted-by":"crossref","first-page":"e000367","DOI":"10.1161\/JAHA.113.000367","article-title":"Cellular encapsulation enhances cardiac repair","volume":"2","author":"Levit","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.retram.2016.04.003_bib0970","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/eurheartj\/ehi818","article-title":"A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction","volume":"27","author":"Freyman","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.retram.2016.04.003_bib0975","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.yjmcc.2008.01.004","article-title":"Homing and engraftment of progenitor cells: a prerequisite for cell therapy","volume":"45","author":"Chavakis","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.retram.2016.04.003_bib0980","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1096\/fj.06-6558com","article-title":"SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction","volume":"21","author":"Zhang","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.retram.2016.04.003_bib0985","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1016\/j.biomaterials.2012.03.039","article-title":"Sustained delivery of SDF-1\u03b1 from heparin-based hydrogels to attract circulating pro-angiogenic cells","volume":"33","author":"Prokoph","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.retram.2016.04.003_bib0990","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehv254","article-title":"Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial","author":"Chung","year":"2015","journal-title":"Eur Heart J"},{"issue":"Suppl. 9","key":"10.1016\/j.retram.2016.04.003_bib0995","first-page":"I150","article-title":"Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials","volume":"112","author":"Hou","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.retram.2016.04.003_bib1000","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/eurjhf\/hfp101","article-title":"Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease","volume":"11","author":"Brunskill","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.retram.2016.04.003_bib1005","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3727\/096368911X603657","article-title":"Percutaneous adventitial delivery of allogeneic bone marrow-derived stem cells via infarct-related artery improves long-term ventricular function in acute myocardial infarction","volume":"21","author":"Medicetty","year":"2012","journal-title":"Cell Transplant"},{"key":"10.1016\/j.retram.2016.04.003_bib1010","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/CIRCINTERVENTIONS.112.000422","article-title":"Optimized delivery system achieves enhanced endomyocardial stem cell retention","volume":"6","author":"Behfar","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.retram.2016.04.003_bib1015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3727\/096368912X661337","article-title":"Intramuscular transplantation of myogenic cells in primates: importance of needle size, cell number, and injection volume","volume":"23","author":"Skuk","year":"2014","journal-title":"Cell Transplant"},{"key":"10.1016\/j.retram.2016.04.003_bib1020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2010.06.039","article-title":"Intra-myocardial biomaterial injection therapy in the treatment of heart failure: materials, outcomes and challenges","volume":"7","author":"Nelson","year":"2011","journal-title":"Acta Biomater"},{"key":"10.1016\/j.retram.2016.04.003_bib1025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.addr.2014.08.006","article-title":"Drug and cell delivery for cardiac regeneration","volume":"84","author":"Hastings","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.retram.2016.04.003_bib1030","doi-asserted-by":"crossref","first-page":"10815","DOI":"10.1021\/nn504617g","article-title":"Cell therapy with embryonic stem cell-derived cardiomyocytes encapsulated in injectable nanomatrix gel enhances cell engraftment and promotes cardiac repair","volume":"8","author":"Ban","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.retram.2016.04.003_bib1035","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.1073\/pnas.1104619108","article-title":"Composite scaffold provides a cell delivery platform for cardiovascular repair","volume":"108","author":"Godier-Furn\u00e9mont","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.retram.2016.04.003_bib1040","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.athoracsur.2008.12.074","article-title":"Cell delivery: intramyocardial injections or epicardial deposition?. A head-to-head comparison","volume":"87","author":"Hamdi","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.retram.2016.04.003_bib1045","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1089\/ten.tea.2011.0391","article-title":"Improving viability of\u00a0stem cells during syringe needle flow through the design of hydrogel cell carriers","volume":"18","author":"Aguado","year":"2012","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.retram.2016.04.003_bib1050","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/cvr\/cvr099","article-title":"Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections","volume":"91","author":"Hamdi","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.retram.2016.04.003_bib1055","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1089\/ten.tea.2010.0659","article-title":"Cardiac cell sheet transplantation improves damaged heart function via superior cell survival in comparison with dissociated cell injection","volume":"17","author":"Sekine","year":"2011","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.retram.2016.04.003_bib1060","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/term.1460","article-title":"Induction of angiogenesis via topical delivery of basic-fibroblast growth factor from polyvinyl alcohol-dextran blend hydrogel in an ovine model of acute myocardial infarction","volume":"7","author":"Fathi","year":"2013","journal-title":"J Tissue Eng Regen Med"},{"key":"10.1016\/j.retram.2016.04.003_bib1065","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/S0142-9612(03)00110-8","article-title":"Cell sheet engineering for myocardial tissue reconstruction","volume":"24","author":"Shimizu","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.retram.2016.04.003_bib1070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/icvts\/ivv076","article-title":"Early and mid-term clinical experience with extracellular matrix scaffold for congenital cardiac and vascular reconstructive surgery: a multicentric Italian study","volume":"21","author":"Padalino","year":"2015","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.retram.2016.04.003_bib1075","doi-asserted-by":"crossref","first-page":"173ra25","DOI":"10.1126\/scitranslmed.3005503","article-title":"Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction","volume":"5","author":"Seif-Naraghi","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.retram.2016.04.003_bib1080","doi-asserted-by":"crossref","first-page":"160sr4","DOI":"10.1126\/scitranslmed.3002717","article-title":"Designing regenerative biomaterial therapies","volume":"4","author":"Pashuck","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.retram.2016.04.003_bib1085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/ten.teb.2013.0668","article-title":"Tissue engineering and regenerative medicine: a year in review","volume":"20","author":"Harrison","year":"2014","journal-title":"Tissue Eng Part B Rev"},{"key":"10.1016\/j.retram.2016.04.003_bib1090","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCRESAHA.114.300522","article-title":"Cardiac tissue engineering: state of the art","volume":"114","author":"Hirt","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.retram.2016.04.003_bib1095","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10439-014-1206-2","article-title":"Clinical applications of naturally derived biopolymer-based scaffolds for regenerative medicine","volume":"43","author":"Stoppel","year":"2015","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.retram.2016.04.003_bib1100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.biomaterials.2007.09.022","article-title":"Assessment of stem cell\/biomaterial combinations for stem cell-based tissue engineering","volume":"29","author":"Neuss","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.retram.2016.04.003_bib1105","doi-asserted-by":"crossref","first-page":"20150254","DOI":"10.1098\/rsif.2015.0254","article-title":"Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review","volume":"12","author":"Tallawi","year":"2015","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.retram.2016.04.003_bib1110","doi-asserted-by":"crossref","first-page":"11507","DOI":"10.1073\/pnas.1004097107","article-title":"Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model","volume":"107","author":"Ifkovits","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.retram.2016.04.003_bib1115","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1089\/ten.tec.2012.0430","article-title":"In vitro perfused human capillary networks","volume":"19","author":"Moya","year":"2013","journal-title":"Tissue Eng Part C Methods"},{"key":"10.1016\/j.retram.2016.04.003_bib1120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.addr.2011.03.004","article-title":"Vascularization is the key challenge in tissue engineering","volume":"63","author":"Novosel","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.retram.2016.04.003_bib1125","doi-asserted-by":"crossref","first-page":"16568","DOI":"10.1073\/pnas.0908381106","article-title":"Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue","volume":"106","author":"Stevens","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.retram.2016.04.003_bib1130","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.1226340","article-title":"Printing and prototyping of tissues and scaffolds","volume":"338","author":"Derby","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.retram.2016.04.003_bib1135","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehv259","article-title":"A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)","author":"Anker","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.retram.2016.04.003_bib1140","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.drudis.2007.05.003","article-title":"Local delivery of proteins and the use of self-assembling peptides","volume":"12","author":"Segers","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.retram.2016.04.003_bib1145","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201400760","article-title":"Advanced imaging approaches for regenerative medicine: emerging technologies for monitoring stem cell fate in vitro and in vivo","author":"Kupfer","year":"2015","journal-title":"Biotechnol J"},{"key":"10.1016\/j.retram.2016.04.003_bib1150","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.cjca.2014.08.028","article-title":"Regenerative cell imaging in cardiac repair","volume":"30","author":"Moudgil","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.retram.2016.04.003_bib1155","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2217\/rme.12.40","article-title":"Assessing commercial opportunities for autologous and allogeneic cell-based products","volume":"7","author":"Smith","year":"2012","journal-title":"Regen Med"},{"key":"10.1016\/j.retram.2016.04.003_bib1160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/scrt488","article-title":"Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?","volume":"5","author":"Lohan","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.retram.2016.04.003_bib1165","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000118784","article-title":"Immunological barriers to embryonic stem cell-derived therapies","volume":"188","author":"Sari\u0107","year":"2008","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.retram.2016.04.003_bib1170","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.stem.2011.01.012","article-title":"Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells","volume":"8","author":"Pearl","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.retram.2016.04.003_bib1175","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/ajt.13477","article-title":"Control of immune response to allogeneic embryonic stem cells by CD3 antibody-mediated operational tolerance induction","volume":"16","author":"Calderon","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.retram.2016.04.003_bib1180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/gt.2014.119","article-title":"Permanent acceptance of mouse cardiac allografts with CD40 siRNA to induce regulatory myeloid cells by use of a novel polysaccharide siRNA delivery system","volume":"22","author":"Zhang","year":"2015","journal-title":"Gene Ther"},{"key":"10.1016\/j.retram.2016.04.003_bib1185","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/imr.12158","article-title":"Induction of transplantation tolerance through regulatory cells: from mice to men","volume":"258","author":"Ferrer","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.retram.2016.04.003_bib1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2015.08.014","article-title":"Controlled release strategies for modulating immune responses to promote tissue regeneration","author":"Dumont","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.retram.2016.04.003_bib1195","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/CIRCULATIONAHA.111.042598","article-title":"Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells","volume":"125","author":"Malliaras","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.retram.2016.04.003_bib1200","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCRESAHA.116.304872","article-title":"Similar effect of autologous and allogeneic cell therapy for ischemic heart disease: systematic review and meta-analysis of large animal studies","volume":"116","author":"Jansen Of Lorkeers","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.retram.2016.04.003_bib1205","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow\u2013derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.retram.2016.04.003_bib1210","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nmat3972","article-title":"Materials for stem cell factories of the future","volume":"13","author":"Celiz","year":"2014","journal-title":"Nat Mater"},{"key":"10.1016\/j.retram.2016.04.003_bib1215","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1073\/pnas.1319685111","article-title":"Combined hydrogels that switch human pluripotent stem cells from self-renewal to differentiation","volume":"111","author":"Dixon","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.retram.2016.04.003_bib1220","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3727\/215517912X653328","article-title":"Bioartificial Renal Epithelial Cell System (BRECS): a compact, cryopreservable extracorporeal renal replacement device","volume":"4","author":"Buffington","year":"2012","journal-title":"Cell Med"},{"issue":"278","key":"10.1016\/j.retram.2016.04.003_bib1225","doi-asserted-by":"crossref","first-page":"278ps4","DOI":"10.1126\/scitranslmed.3010496","article-title":"Stem cell hype: media portrayal of therapy translation","volume":"7","author":"Kamenova","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.retram.2016.04.003_bib1230","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318616300058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318616300058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T08:57:06Z","timestamp":1536656226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318616300058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":123,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S2452318616300058"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2016.04.003","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cells for the treatment of heart failure","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2016.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}